What dosages of Wellbutrin (bupropion) cause orthostatic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Wellbutrin (bupropion) can cause orthostatic hypotension, particularly at high doses, and patients with cardiovascular diseases are at a greater risk, as reported in the most recent study 1. When considering the dosages of Wellbutrin that may cause orthostatic hypotension, it's essential to look at the most recent and highest quality study available. According to the 2021 study published in Frontiers in Cardiovascular Medicine 1, bupropion can lead to blood pressure increases, usually at high doses, but may also cause orthostatic hypotension, especially in patients with cardiovascular diseases.

Key Points to Consider

  • Orthostatic hypotension may occur during initial treatment or after dose increases
  • Elderly patients, those with pre-existing cardiovascular conditions, or patients taking other medications that lower blood pressure are at a higher risk
  • To minimize this risk, start with a lower dose of Wellbutrin (usually 150 mg once daily) and gradually increase if needed, allowing the body to adjust
  • Take the medication with food to slow absorption and reduce peak blood levels
  • If orthostatic symptoms occur (dizziness, lightheadedness, or fainting when standing), patients should change positions slowly, stay hydrated, and report these symptoms to their healthcare provider

Mechanism and Precautions

The mechanism behind Wellbutrin-induced orthostatic hypotension involves its effects on norepinephrine and dopamine neurotransmission, which can influence blood vessel tone and cardiovascular regulation, as discussed in the study 1. Clinicians should carefully consider their patients' blood pressure status and cardiovascular comorbidities when prescribing Wellbutrin, due to its potential effects on blood pressure profiles and interactions with antihypertensive treatments.

Comparison with Other Studies

While earlier studies, such as those from 1991 2, 1983 3, 1992 4, and 1994 5, provide valuable insights into the effects of bupropion, the most recent study from 2021 1 offers the most up-to-date and comprehensive understanding of the relationship between Wellbutrin and orthostatic hypotension. Therefore, its findings should be prioritized when making clinical decisions.

References

Research

Antidepressant Drugs Effects on Blood Pressure.

Frontiers in cardiovascular medicine, 2021

Research

Falling backward in two elderly patients taking bupropion.

The Journal of clinical psychiatry, 1992

Research

The cardiovascular effects of bupropion and nortriptyline in depressed outpatients.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994

Related Questions

Can Wellbutrin (bupropion) cause hypertension?
Can bupropion (Wellbutrin), sertraline (Zoloft), donepezil, or quetiapine (Seroquel) contribute to hypotension?
What are the management options for hypertension in patients taking Wellbutrin (bupropion)?
Can bupropion (Bupropion) SR (Sustained Release) cause hypertension?
Can Wellbutrin (bupropion) cause hypertension?
How to differentiate between hepatic (liver) adenoma and hepatic (liver) hemangioma?
What cross-links elastin and what are the resulting products, specifically the role of lysyl oxidase (LOX) in forming desmosine and isodesmosine?
What is the most appropriate treatment for a 72-year-old man with hyperthermia (elevated body temperature), hypotension (low blood pressure), tachycardia (rapid heart rate), and somnolence, suspected to have heat-related illness, who is taking Hydrochlorothiazide (a diuretic) and Lisinopril (an angiotensin-converting enzyme inhibitor) for hypertension?
What is the most appropriate additional management for a 61-year-old woman with a chronic obstructive pulmonary disease (COPD) exacerbation, characterized by increased dyspnea and purulent sputum production, who is already on mometasone furoate (mometasone)-formoterol, tiotropium bromide, and albuterol inhalers, and has been initiated on nebulized albuterol and oral azithromycin (azithromycin), with normal body temperature, hypertension, tachycardia, mild tachypnea, and normal oxygen saturation on supplemental oxygen?
What are the causes of schistocytes in a cancer patient?
Does Lenvima (lenvatinib) cause photosensitivity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.